Working toward drug plan sustainability

Biosimilars, generics among tools that can help ensure employee health

Working toward drug plan sustainability

Health care remains a fundamental and defining issue for Canadians. As such, ensuring that private drug plans evolve with Canada’s changing health-care landscape is of great importance. 

To read the full story, login below.

Not a subscriber?

Start your subscription today!